Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Harefuah
|
April 1, 2011
[Over the counter drugs--a new era in Israel]
Ifat Abadi-Korek, Sharona Vaknin, Eli Marom, et al.
The Israel Medical Association Journal : IMAJ
|
January 24, 2009
A decade to the Israeli Center for Technology Assessment in Health Care
Orly Tamir, Joshua Shemer, Mordechai Shani, et al.
Diabetes/Metabolism Research and Reviews
|
October 13, 2011
The patient-perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care
Orly Tamir, Julio Wainstein, Ifat Abadi-Korek, et al.
Harefuah
|
April 7, 2011
[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions]
Sharon Furman-Assaf, Orly Tamir, Eli Marom, et al.
The American Journal of Cardiology
|
October 2, 2012
Continuation of statin therapy and primary prevention of nonfatal cardiovascular events
Varda Shalev, Inbal Goldshtein, Avi Porath, et al.
The Israel Medical Association Journal : IMAJ
|
June 15, 2012
The games go on: British Medical Journals play politics, again
Yehuda Shoenfeld, Joshua Shemer, Gad Keren, et al.
Emerging Health Threats Journal
|
March 31, 2012
Optimism of health care workers during a disaster: a review of the literature
Noga Boldor, Yosefa Bar-Dayan, Tova Rosenbloom, et al.
The Israel Medical Association Journal : IMAJ
|
August 25, 2009
British medical journals play politics
Yehuda Shoenfeld, Joshua Shemer, Gad Keren, et al.
International Journal of Technology Assessment in Health Care
|
November 6, 2023
Priority setting for health technology adoption at the national level: Lessons learned over 25 years' experience
Osnat Luxenburg, Tal Morginstin, Vicki Myers, et al.
Harefuah
|
April 7, 2011
[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats]
Orly Tamir, Naomi Friedman, Sharon Furman-Assaf, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Harefuah
|
April 1, 2011
[Over the counter drugs--a new era in Israel]
Ifat Abadi-Korek, Sharona Vaknin, Eli Marom, et al.
The Israel Medical Association Journal : IMAJ
|
January 24, 2009
A decade to the Israeli Center for Technology Assessment in Health Care
Orly Tamir, Joshua Shemer, Mordechai Shani, et al.
Diabetes/Metabolism Research and Reviews
|
October 13, 2011
The patient-perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care
Orly Tamir, Julio Wainstein, Ifat Abadi-Korek, et al.
Harefuah
|
April 7, 2011
[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions]
Sharon Furman-Assaf, Orly Tamir, Eli Marom, et al.
The American Journal of Cardiology
|
October 2, 2012
Continuation of statin therapy and primary prevention of nonfatal cardiovascular events
Varda Shalev, Inbal Goldshtein, Avi Porath, et al.
The Israel Medical Association Journal : IMAJ
|
June 15, 2012
The games go on: British Medical Journals play politics, again
Yehuda Shoenfeld, Joshua Shemer, Gad Keren, et al.
Emerging Health Threats Journal
|
March 31, 2012
Optimism of health care workers during a disaster: a review of the literature
Noga Boldor, Yosefa Bar-Dayan, Tova Rosenbloom, et al.
The Israel Medical Association Journal : IMAJ
|
August 25, 2009
British medical journals play politics
Yehuda Shoenfeld, Joshua Shemer, Gad Keren, et al.
International Journal of Technology Assessment in Health Care
|
November 6, 2023
Priority setting for health technology adoption at the national level: Lessons learned over 25 years' experience
Osnat Luxenburg, Tal Morginstin, Vicki Myers, et al.
Harefuah
|
April 7, 2011
[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats]
Orly Tamir, Naomi Friedman, Sharon Furman-Assaf, et al.
Page
of 7